Fund detail
Baillie Gifford
large-active, growth, lo
Quarters
52
2024-12-31
$130.14B
Positions
271
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.
| # | Issuer | Value ↑ | Weight | Shares | Share Δ | Share Δ % | Prev Weight | First Held | Price | Est. Cost | Unrealized % | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 10X Genomics Inc Class A | $0 | 0 | -40,378 | -100.00% | 0.00% | ||||||
| 2 | Alector Inc | $0 | 0 | -78,835 | -100.00% | 0.00% | ||||||
| 3 | Ascendis Pharma ADR 1:1 | $0 | 0 | -21,403 | -100.00% | 0.00% | ||||||
| 4 | BCE Inc | $0 | 0 | -31,257 | -100.00% | 0.00% | ||||||
| 5 | Brookfield Renewable | $0 | 0 | -418,371 | -100.00% | 0.01% | ||||||
| 6 | CRISPR Therapeutics AG | $0 | 0 | -364,768 | -100.00% | 0.01% | ||||||
| 7 | Exscientia Ltd ADR | $0 | 0 | -3,848,276 | -100.00% | 0.01% | ||||||
| 8 | Health Catalyst Inc | $0 | 0 | -121,855 | -100.00% | 0.00% | ||||||
| 9 | Intel Corporation | $0 | 0 | -700 | -100.00% | 0.00% | ||||||
| 10 | Ionis Pharmaceuticals | $0 | 0 | -39,581 | -100.00% | 0.00% | ||||||
| 11 | Lyell Immunopharma Inc | $0 | 0 | -141,949 | -100.00% | 0.00% | ||||||
| 12 | Mettler-Toledo | $0 | 0 | -97,005 | -100.00% | 0.11% | ||||||
| 13 | ResMed | $0 | 0 | -15,500 | -100.00% | 0.00% | ||||||
| 14 | Vir Biotechnology Inc | $0 | 0 | -2,383,029 | -100.00% | 0.01% | ||||||
| 15 | Zuora Inc Class A | $0 | 0 | -2,454,747 | -100.00% | 0.02% | ||||||
| 16 | Scilex Hdg SCLXUSD | $223 | 0.00% | 523 | +0 | +0.00% | 0.00% | 2023-03-31 | $0 | ~$8 | -94.80% | |
| 17 | Genmab ADR GMAB | $1K | 0.00% | 54 | +0 | +0.00% | 0.00% | 2023-12-31 | $21 | ~$31 | -33.45% | |
| 18 | Li Auto ADR LI | $3K | 0.00% | 112 | +72 | +180.00% | 0.00% | 2021-03-31 | $24 | ~$26 | -6.14% | |
| 19 | Total Fina ADR TTEN | $3K | 0.00% | 58 | +58 | 2024-12-31 | $54 | ~$54 | +0.00% | |||
| 20 | Novo Nordisk 'B' Adr 1:1 NVO | $5K | 0.00% | 53 | +0 | +0.00% | 0.00% | 2024-03-31 | $86 | ~$131 | -34.46% | |
| 21 | Anheuser-Busch Inbev ADR BUD | $5K | 0.00% | 100 | +0 | +0.00% | 0.00% | 2023-12-31 | $50 | ~$65 | -22.49% | |
| 22 | Rio Tinto Spn.Adr 1:1 RIO | $19K | 0.00% | 319 | +37 | +13.12% | 0.00% | 2014-09-30 | $59 | ~$66 | -10.52% | |
| 23 | Unilever Spn.Adr 1:1 | $23K | 0.00% | 398 | +87 | +27.97% | 0.00% | 2024-03-31 | $57 | ~$55 | +2.77% | |
| 24 | Veeva Systems Inc Class A VEEV | $23K | 0.00% | 110 | -15,239 | -99.28% | 0.00% | 2020-12-31 | $210 | ~$245 | -14.23% | |
| 25 | Stantec Inc STN | $31K | 0.00% | 389 | +89 | +29.67% | 0.00% | 2024-09-30 | $78 | ~$80 | -2.31% | |
| 26 | CRH Plc | $35K | 0.00% | 379 | -12 | -3.07% | 0.00% | 2023-09-30 | $93 | ~$68 | +36.84% | |
| 27 | Teradyne TER | $39K | 0.00% | 312 | +22 | +7.59% | 0.00% | 2013-06-30 | $126 | ~$29 | +332.28% | |
| 28 | Nucana Plc ADR | $44K | 0.00% | 36,704 | +0 | +0.00% | 0.00% | 2024-06-30 | $1 | ~$3 | -53.88% | |
| 29 | Sutro Biopharma | $90K | 0.00% | 48,791 | -1,470,550 | -96.79% | 0.00% | 2020-06-30 | $2 | ~$9 | -79.27% | |
| 30 | Spire Global Inc SPIR | $187K | 0.00% | 13,259 | +0 | +0.00% | 0.00% | 2023-09-30 | $14 | ~$5 | +187.73% |